Cargando…
Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement
Patient: Female, 29-year-old Final Diagnosis: Refractory Hodgkin lymphoma with CNS involvement Symptoms: Blurred vision Medication: — Clinical Procedure: — Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: CNS involvement in Hodgkin lymphoma is rare. Despite various treatment options, median...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scientific Literature, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083218/ https://www.ncbi.nlm.nih.gov/pubmed/32170052 http://dx.doi.org/10.12659/AJCR.921657 |